Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
Selexipag, a selective prostacyclin receptor agonist, is approved for treating pulmonary arterial hypertension in WHO Group 1 adult patients. Compared to parenteral prostacyclin formulations, selexipag offers a significant improvement in patient’s and caregiver’s quality of life because of its oral...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-03-01
|
| Colección: | Frontiers in Pediatrics |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fped.2023.1050508/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|